AUSTIN, TX — (Marketwired) — 08/05/13 — EPIC Corporation (PINKSHEETS: EPOR) (“EPIC”), and Ronald S. Tucker, EPIC-s president, announced that “EPIC-s earnings, for nine months, are $1,827,877 or $0.17 per undiluted share.”
“EPIC, for its nine months ending June 30, 2013, increased its capital by $2,264,262 since September 30, 2012, has net profit of $1,827,877 or $0.17 per undiluted share. The net profit is based on a total number of shares issued and outstanding of 10,669,355 with a float of 4,060,000 shares as of June 30, 2013,” said Mr. Tucker. “EPIC-s performance is a the result of granting a worldwide exclusive license for $1,950,000 in exchange of common stock of a developing special purpose finance company in Europe.”
EPIC-s management stated in its Press Release of July 27, 2013, “EPIC has a recapitalization and business structure reorganization program …to emphasize and demonstrate …[how with] the effective use of capital EPIC and its shareholders will realize increases in …capital growth and capital value.” The results demonstrate the effectiveness of EPIC-s program which includes the development of a joint venture in Europe.
EPIC stated in its Press Release of July 24, 2013, “EPIC granted the License to a European Company that is developing distribution of AcuFAB fabric and AcuPAD products made from AcuFAB in Europe and other part[s] of the world including the US,” said Mr. Tucker. “As consideration for the License EPIC acquires a 27.3% interest in the European Company, and EPIC will also receive one fourth (1/4) of any sublicense the European company may grant. EPIC will also receive a commission on the purchase of the fabric by the European Company or its sublicensees.”
EPIC is a special purpose financial services company that provides corporate, business and financial services to subsidiaries, affiliates and third parties, with a focus on healthcare and medical products and service companies. Visit for corporate information and for investor and financial information.